540 GAITHER ROAD, ROCKVILLE, MD
Director Departures - Dr. Jonathan Goldman and Mitchell Chan Not Standing for...
Financial Results, Press Release
Investor Presentation
Reports Third Quarter 2025 Financial Results and Recent Business Updates
Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
Expands Leadership Team with Key Appointments in Business Development and Human Resources
FY 2025
Q3
Q2
Q1
FY 2024
Q2 amended
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report